CD10 is not a reliable tool for identification of early myometrial invasion in endometrial adenocarcinomas.
D000230:Adenocarcinoma / Q000737:chemistry / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis; D016889:Endometrial Neoplasms / Q000737:chemistry / Q000473:pathology*; D005260:Female; D006801:Humans; D009215:Myometrium / Q000737:chemistry / Q000473:pathology*; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D015260:Neprilysin / Q000032:analysis
D014408:Biomarkers, Tumor; D015260:Neprilysin